Compare PCG & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCG | MDLN |
|---|---|---|
| Founded | 1995 | 1966 |
| Country | United States | United States |
| Employees | 29000 | 45000 |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0B | 37.4B |
| IPO Year | N/A | N/A |
| Metric | PCG | MDLN |
|---|---|---|
| Price | $16.62 | $35.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 23 |
| Target Price | $22.19 | ★ $50.48 |
| AVG Volume (30 Days) | ★ 17.4M | 11.1M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.24 | $10.88 |
| Revenue Next Year | $3.41 | $7.69 |
| P/E Ratio | ★ $15.15 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.97 | $32.82 |
| 52 Week High | $19.16 | $50.88 |
| Indicator | PCG | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 49.89 | 41.25 |
| Support Level | $16.05 | N/A |
| Resistance Level | $16.90 | $44.89 |
| Average True Range (ATR) | 0.40 | 1.59 |
| MACD | 0.07 | 0.09 |
| Stochastic Oscillator | 43.72 | 47.36 |
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision in 2001-04 during California's energy crisis and in 2019-20 due to wildfire losses. In 2004, PG&E sold its unregulated assets as part of its first postbankruptcy reorganization.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.